May 6, 2020
GRAIL in $390 Million series D financing round
Inc., a healthcare company whose mission is to detect cancer early, when it can be cured, today announced a $390 million Series D financing round.
Pharmaceuticals, Biotechnology and Life Sciences
Category: North America
May 6, 2020
Ironwood increases total revenue by 16% to $80 in Q1 from last year same period
Ironwood has increased total revenue by 16% year-over-year to $80 million, driven primarily by U.S. LINZESS collaboration revenue of $71 million.
May 6, 2020
Ligand’s net loss in Q1 2020 went to $24.1 million from profit of $666.3 million in Q1 2019
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today reported financial results for the first quarter with strong sales of Captisol to partners evaluating remdesivir in multiple clinical trials and scaling-up for potential treatment courses for COVID-19
May 6, 2020
Atara reports net losses of $73.5 million in Q1 2020
Atara reported net losses of $73.5 million, or $1.20 per share, for the first quarter of 2020 as compared to $66.3 million, or $1.44 per share, for the same period in 2019, with the total operating expenses include non-cash expenses of $14.5 million for the first quarter 2020, as compared to $13.9 million for the same period in 2019.
May 6, 2020
Rocket posts balance sheet with $275.9 million in cash, capitalized into 2022
Rocket Pharmaceuticals has reported a strong balance sheet with $275.9 million in cash, capitalized into 2022.
May 6, 2020
Spruce Biosciences has new CFO and new VP pharma development and manufacturing
Spruce Biosciences has announced the appointments of Samir Gharib, MBA, CPA, as Chief Financial Officer (CFO), and Dasharatha Reddy, Ph.D., as Vice President, Pharmaceutical Development and Manufacturing.
May 6, 2020
Alnylam Pharmaceuticals ends Q1 2020 with net product revenues of $71.94M
Alnylam Pharmaceuticals ends Q1 2020 with net product revenues of $71.94M
May 6, 2020
Acerus’s Norma Beauchamp in resignation as director
TORONTO–(BUSINESS WIRE)–Acerus Pharmaceuticals Corporation (TSX:ASP, OTCQB:ASPCF) (“Acerus” or the “Company”) announced that Norma Beauchamp has resigned as a member of…
May 6, 2020
Laurent Pharmaceuticals Receives Health Canada’s Approval to Initiate COVID-19 Clinical Trial
Company to test LAU-7b’s dual pro-resolving inflammation and antiviral properties against COVID-19 MONTREAL–(BUSINESS WIRE)–Laurent Pharmaceuticals Inc., a Montreal-based biopharmaceutical company,…
May 6, 2020
InteRNA Technologies Receives Regulatory Approval for Initiation of Phase I Clinical Trial of INT-1B3 in Patients with Advanced Solid Tumors
— First-in-human trial will test the safety, pharmacokinetics and preliminary efficacy of microRNA therapeutic candidate INT-1B3 — UTRECHT, The Netherlands–(BUSINESS…